Showing results (281-290 of 658) with videos related to
Sort By:
Pageof 66
Cell Reports|October 1, 2023
Widespread impact of immunoglobulin V-gene allelic polymorphisms on antibody reactivityMeng Yuan, Ziqi Feng, Huibin Lv, et al.Nature Communications|December 21, 2022
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation siteDaniel Stadlbauer, Meagan McMahon, Hannah L Turner, et al.Biorxiv : the Preprint Server for Biology|September 4, 2024
Vaccines combining slow delivery and follicle targeting of antigens increase germinal center B cell clonal diversity and clonal expansionKristen A Rodrigues, Yiming J Zhang, Aereas Aung, et al.Science Advances|March 28, 2025
Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineagesCaroline K Page, Justin D Shepard, Sean D Ray, et al.Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformationRajesh P Ringe, Rogier W Sanders, Anila Yasmeen, et al.Communications Biology|May 15, 2023
Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccineJohn V Dzimianski, Julianna Han, Giuseppe A Sautto, et al.Biorxiv : the Preprint Server for Biology|July 19, 2024
Structural Mapping of Polyclonal IgG Responses to HA After Influenza Virus Vaccination or InfectionAndré Nicolás León, Alesandra J Rodriguez, Sara T Richey, et al.Proceedings of the National Academy of Sciences of the United States of America|February 22, 2013
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9Jean-Philippe Julien, Jeong Hyun Lee, Albert Cupo, et al.Nature Communications|January 23, 2026
An H5N1 clade 2.3.4.4b virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteinsEduard Puente-Massaguer, Thales Galdino Andrade, Michael J Scherm, et al.Journal of Pharmaceutical Sciences|February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine AntigensNeal Whitaker, John M Hickey, Kawaljit Kaur, et al.Pageof 66